PMID: 15239395Jul 9, 2004Paper

Diverse clinical applications using advantages of allogeneic peripheral blood stem cell transplantation

International Journal of Hematology
Sang Kyun SohnKyu Bo Lee

Abstract

The diverse clinical applications of allogeneic peripheral blood stem cells based on use of their advantages are summarized. It is apparent that more stem cells and T-lymphocytes can be harvested by mobilization treatment with cytokines from healthy donors in allogeneic peripheral blood stem cell transplantation (PBSCT) than in bone marrow transplantation. It is also clear that a stronger graft-versus-tumor effect can be induced with allogeneic PBSCT than with bone marrow transplantation. One merit of allogeneic PBSCT is that it allows clinicians to design diverse clinical applications. It would appear that allogeneic PBSCT may be preferable in special clinical settings, such as advanced hematological malignancies, situations requiring a strong graft-versus-tumor effect, nonmyeloablative stem cell transplantation, and situations requiring a megadose of stem cells. Cytokine-primed peripheral blood stem cells can also be used for adoptive immunotherapy, such as a nonprimed donor lymphocyte infusion.

References

Oct 3, 1998·Bone Marrow Transplantation·M M AbecasisM Jorge
Dec 16, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I F KhouriR Champlin
Jul 25, 2000·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·T R SpitzerM Sykes
Jul 4, 2001·Bone Marrow Transplantation·A GratwohlUNKNOWN European Group for Blood and Marrow Transplantation (EBMT)
Aug 16, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C CutlerJ H Antin
Jan 12, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·John E LevineRobert H Collins
May 31, 2002·Blood·Philippe GuardiolaUNKNOWN Subcommittee for Myelodysplastic Syndromes of the Chronic Leukaemia Working Group of the European Blood and Marrow Transplan
Jul 20, 2002·Blood·Norbert SchmitzUNKNOWN European Group for Blood and Marrow Transplantation
Dec 19, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·O RingdénF Frassoni
Jun 28, 2003·Blood·Norbert C GorinUNKNOWN European Cooperative Group for Blood and Marrow Transplantation Acute Leukemia Working Party

❮ Previous
Next ❯

Citations

Jul 19, 2006·Journal of Clinical Apheresis·Claudia Del FanteLaura Salvaneschi
Jan 21, 2006·Journal of Clinical Apheresis·Sang Kyun SohnDong Hwan Kim

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.